Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

2.630 -0.150 (-5.40%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NRX Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Mid-Afternoon Market Update: Dow Rises Over 50 Points; ImmunoPrecise Antibodies Shares Spike Higher
Toward the end of trading Thursday, the Dow traded up 0.16% to 34,853.89 while the NASDAQ rose 0.38% to 14,687.85. The S&P also rose, gaining 0.20% to 4,367.55. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
NRXP Stock: This Covid-19 Treatment Could Prime NRx Pharmaceuticals for Big Gains
NRXP stock came to investors' attention last year with its Covid-19 treatment. Now, it's looking like a great play as it eyes up EUA. 
Via InvestorPlace
Exposures COVID-19
38 Stocks Moving In Thursday's Mid-Day Session
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating... 
Via Benzinga
Mid-Day Market Update: Crude Oil Up 1.5%; Seres Therapeutics Shares Plunge
Midway through trading Thursday, the Dow traded down 0.08% to 34,768.64 while the NASDAQ rose 0.10% to 14,646.39. The S&P also fell, dropping 0.02% to 4,357.70. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 53.01% to $15.47 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume... 
Via Benzinga
Why NRx Pharmaceuticals Stock Is Soaring Today
The company achieved two breakthroughs related to the formulation and manufacturing of Zyesami, its experimental COVID-19 drug. 
Via The Motley Fool
Exposures COVID-19
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical... 
Via Benzinga
Exposures Product Safety
62 Biggest Movers From Yesterday
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NeuroMetrix (NASDAQ:NURO) shares moved upwards by 177.6% to $9.05 during Tuesday's regular session. As of 12:30 EST, NeuroMetrix's stock is trading at a... 
Via Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock moved upwards by 36.87% to $3.86 during Tuesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
NRXP Stock: The ‘Cykotine Storm’ Drug News Sending NRx Pharma Shares Soaring
Shares of NRXP stock are taking off on Monday after the pharmaceutical company reported positive results regarding its Zyesami trial. 
Via InvestorPlace
Exposures COVID-19
54 Biggest Movers From Yesterday
Gainers Aehr Test Systems (NASDAQ: AEHR) shares climbed 87.9% to close at $6.39 on Monday after the company won a $10.8 million single purchase order from its lead silicon... 
Via Benzinga
Why NRx Pharmaceuticals Stock Is Skyrocketing Today
The company reported promising data for its experimental COVID-19 drug Zyesami. 
Via The Motley Fool
Exposures COVID-19
Mid-Day Market Update: Crude Oil Dips 6%; Cytokinetics Shares Spike Higher
Midway through trading Monday, the Dow traded down 2.28% to 33,896.40 while the NASDAQ fell 1.31% to 14,238.93. The S&P also fell, dropping 1.74% to 4,251.79. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
30 Stocks Moving In Monday's Mid-Day Session
Gainers Cytokinetics, Incorporated (NASDAQ: CYTK) jumped 56.4% to $30.07 after the company disclosed topline results from Cohorts 1 and 2 of REDWOOD-HCM. Aehr Test Systems (... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; AutoNation Profit Beats Estimates
Following the market opening Monday, the Dow traded down 2.31% to 33,885.81 while the NASDAQ fell 1.67% to 14,186.04. The S&P also fell, dropping 1.94% to 4,243.38. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
NRx Pharma Stock Surges As Its COVID-19 Candidate Shows Evidence To Prevent "Cytokine Storm"
NRx Pharmaceuticals (NASDAQ: NRXP) identifies a statistically significant effect of Zyesami (aviptadil) in preventing the sharp rise in cytokines, commonly associated... 
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. The company's market cap stands at $684.2... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 68 companies hit new 52-week lows. Points of Interest: TotalEnergies (NYSE:TTE) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers scPharmaceuticals (NASDAQ:SCPH) ... 
Via Benzinga
40 Stocks Moving In Friday's Mid-Day Session
Gainers Stamps.com Inc. (NASDAQ: STMP) jumped 63.7% to $323.63. Software investment firm Thoma Bravo inked an agreement to acquire e-commerce shipping solutions provider Stamps.... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers MediaCo Holding Inc. (NASDAQ: MDIA) shares jumped 311.6% to close at $17.00 on Monday after jumping 20% on Friday. State Auto Financial Corporation (NASDAQ: STFC) shares... 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 29 stocks hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was CoStar Gr (... 
Via Benzinga
64 Biggest Movers From Friday
Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares surged 597.8% to settle at $34.89 on Friday as the company priced its IPO at $5 per share. SGOCO Group, Ltd. (NASDAQ: SGOC)... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
NRx Pharma Stock Is Trading Higher On Positive Aviptadil Data From Expanded Access Protocol In COVID-19 Patients
NRx Pharmaceuticals Inc (NASDAQ: NRXP) has announced positive data from its Zyesami (Aviptadil) Expanded Access Protocol (EAP) in patients with critical... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 8) Aerpio Pharmaceuticals, Inc... 
Via Benzinga
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
Via Benzinga
Topics Product Recall
Exposures COVID-19 Legal Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Clearside Biomedical (NASDAQ:CLSD) stock increased by 50.99% to $4.56 during Tuesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares jumped 371% to $10.41 in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.